Log in to save to my catalogue

Multi-country evaluation of RISK6, a 6-gene blood transcriptomic signature, for tuberculosis diagnos...

Multi-country evaluation of RISK6, a 6-gene blood transcriptomic signature, for tuberculosis diagnos...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_de33777566a645f5adea0e0e7f01b111

Multi-country evaluation of RISK6, a 6-gene blood transcriptomic signature, for tuberculosis diagnosis and treatment monitoring

About this item

Full title

Multi-country evaluation of RISK6, a 6-gene blood transcriptomic signature, for tuberculosis diagnosis and treatment monitoring

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2021-07, Vol.11 (1), p.13646-13646, Article 13646

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

There is a crucial need for non-sputum-based TB tests. Here, we evaluate the performance of RISK6, a human-blood transcriptomic signature, for TB screening, triage and treatment monitoring. RISK6 performance was also compared to that of two IGRAs: one based on RD1 antigens (QuantiFERON-TB Gold Plus, QFT-P, Qiagen) and one on recombinant
M. tuber...

Alternative Titles

Full title

Multi-country evaluation of RISK6, a 6-gene blood transcriptomic signature, for tuberculosis diagnosis and treatment monitoring

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_de33777566a645f5adea0e0e7f01b111

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_de33777566a645f5adea0e0e7f01b111

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-021-93059-1

How to access this item